Erythropoietin, uncertainty principle and cancer related anaemia.
Clark O, Adams JR, Bennett CL, Djulbegovic B
BMC Cancer 2002;2(1):23.
Review by
Combining anchor and distribution-based methods to derive minimal clinically important differences on the functional assessment of cancer therapy (FACT) anemia and fatigue scales.
Cella D, Eton DT, Lai JS, Peterman AH, Merkel DE
J Pain Symptom Manage 2002;24(6):547-561.
Review by Ford PA
The clinical value of erythropoietin in patients with cancer.
Duhrsen U
Drugs 2002;62(14):2013-2023.
Review by
Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology.
Rizzo JD, Lichtin AE, Woolf SH, et al.
Blood 2002;100(7):2303-2320.
Review by
NATA: Network for the Advancement of Patient Blood Management, Haemostasis and Thrombosis
MISSION: Providing a multidisciplinary forum for dialogue between haematologists, transfusion medicine specialists, anaesthesiologists, intensive care and emergency physicians, surgeons, perfusionists, nurses, biomedical scientists and other healthcare professionals.
Sitemap
Contact us
- secretary@nataonline.com
-
NATA
Rue de l’Industrie 24
1040 Bruxelles - VAT: 0781668659